Brain drug target discovery in MS
US researchers have found two potential targets for treating multiple sclerosis after an extensive trawl through proteins in the brain. Comparison of 2,538 proteins from MS patients with those from healthy brains showed damage in two proteins not before linked to the disease. In mice blocking the effects of the proteins led to reversal of symptoms, the study in Nature reported.